Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Pediatric Recurrent Respiratory Papillomatosis
NCT01058317Phase 3Withdrawn
- Sponsor
- Massachusetts Eye and Ear
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of propranolol in recurrent respiratory papillomatosis (RRP), sponsored by Massachusetts Eye and Ear. Planned start Jan 2010; status: withdrawn.
02
Drugs
propranolol
03
Conditions
recurrent respiratory papillomatosis (RRP)
Beyond the preview
Go deeper on NCT01058317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01058317.